NCT06685757 · Interventional trial
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR)
Overall registry status Active not recruiting
Phase 3
Conditions Antibody-mediated Rejection
Delaware Valley sites
- Penn Medicine - Hospital of the University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory